Related Experiment Video
Updated: Jul 15, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Increased pontin expression in human colorectal cancer tissue
Johannes C Lauscher1, Christoph Loddenkemper2, Luise Kosel3
1Department of General, Vascular and Thoracic Surgery, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, D-12200 Berlin, Germany.
Human Pathology
|April 20, 2007
Summary
Pontin protein is upregulated and found in the nucleus of colorectal cancer cells, suggesting it contributes to cancer progression alongside beta-catenin.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Wnt signaling is crucial for cell growth and differentiation, and its dysregulation is common in colorectal cancer.
- Pontin, an AAA(+) superfamily member, interacts with beta-catenin and enhances Wnt target gene transcription, potentially promoting carcinogenesis.
Purpose of the Study:
- To investigate pontin expression in colorectal cancer tissues.
- To correlate pontin expression patterns with tumor characteristics and beta-catenin localization.
Main Methods:
- Immunohistochemistry was used to assess pontin expression in 34 colorectal cancer samples.
- Western blotting was performed on 8 patient samples to confirm immunohistochemical findings.
Main Results:
- Pontin was overexpressed in tumor cells compared to normal mucosa in all cases.
- Nuclear pontin staining was observed in 50% of tumors, correlating with nuclear beta-catenin.
- Increased pontin expression was noted at the invasive margin and in tumor buds, associated with enhanced beta-catenin.
Conclusions:
- Upregulation and nuclear localization of pontin, along with beta-catenin, may play a role in colorectal carcinoma progression.
- Pontin's association with invasive features suggests its involvement in metastasis.
